epidepride has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KW; Chen, MW; Cheng, KH; Huang, YR; Kuo, WI; Pai, CW | 1 |
| Chang, KW; Chen, CC; Huang, C; Huang, YR; Shih, JM; Wu, YL | 1 |
2 other study(ies) available for epidepride and Chronic Disease
| Article | Year |
|---|---|
Dopamine D(2)/D(3) receptor binding of [(123)I]epidepride in risperidone-treatment chronic MK-801-induced rat schizophrenia model using nanoSPECT/CT neuroimaging.
Topics: Animals; Benzamides; Chronic Disease; Disease Models, Animal; Dizocilpine Maleate; Male; Multimodal Imaging; Neuroimaging; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tyrosine 3-Monooxygenase | 2014 |
[123I]Epidepride neuroimaging of dopamine D2/D3 receptor in chronic MK-801-induced rat schizophrenia model.
Topics: Animals; Behavior, Animal; Benzamides; Chronic Disease; Disease Models, Animal; Dizocilpine Maleate; Iodine Radioisotopes; Male; Multimodal Imaging; Neostriatum; Neuroimaging; Positron-Emission Tomography; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Tomography, X-Ray Computed; Tyrosine 3-Monooxygenase | 2012 |